ProCuta PDRN Pink Peptide Serum | Salmon DNA (PDRN), 15 Peptide Complex, 16 Hyaluronic Acid Complex, 5 Ceramides, Niacinamide & Alpha Arbutin | Anti-Ageing & Hydrating Face Serum | 30ml
Original price was: ₹999.00.₹359.00Current price is: ₹359.00.
- Advanced PDRN peptide serum with five powerful actives – ProCuta PDRN Pink Peptide Serum combines PDRN (Salmon DNA), 15 Peptide Complex, 16 Hyaluronic Acid Complex, 5 Ceramides, Niacinamide, and Alpha Arbutin in one advanced face serum. This anti-ageing serum helps improve the appearance of fine lines, supports skin renewal, and promotes smoother, firmer, and healthier-looking skin.
- Deep hydration with hyaluronic acid and ceramides – Powered by a 16 Hyaluronic Acid Complex and 5 Ceramides, this hydrating face serum delivers long-lasting moisture while helping strengthen the skin’s natural moisture barrier. It leaves skin feeling soft, plump, nourished, and refreshed without a greasy finish.
- Brightens dull skin and improves uneven skin tone – Formulated with Niacinamide and Alpha Arbutin, this brightening serum helps reduce the appearance of dullness, uneven skin tone, and post-acne marks. Regular use promotes a more radiant, even-looking complexion with a healthy natural glow.
- Lightweight, fast-absorbing, and non-sticky formula – This lightweight pink face serum features a naturally tinted Vitamin B12 formula that absorbs quickly into the skin without leaving any sticky residue. Perfect for daily skincare, it layers comfortably under moisturiser, sunscreen, and makeup for a fresh, dewy finish.
- Suitable for all skin types and daily skincare routines – Designed for women and men, this facial serum is suitable for dry, oily, combination, and normal skin. Use morning and evening to help improve skin texture, enhance skin firmness, support the moisture barrier, and achieve hydrated, glowing, youthful-looking skin.
Add a review
Your review
* Review is required
Name
* Name is required
Email
* Email is required
Add photos or video to your review
Reviews
There are no reviews yet